Table of contents
Volume 99, Issue 8
Published online 14 October 2008 (1197-1368)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Letters to the Editor
Minireviews
mTORC1 inhibitors: is temsirolimus in renal cancer telling us how they really work? FREE
C Le Tourneau, S Faivre, M Serova and E Raymond
Br J Cancer 99: 1197-1203; advance online publication, September 16, 2008; doi:10.1038/sj.bjc.6604636
VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis FREE
G Thurston and J Kitajewski
Br J Cancer 99: 1204-1209; advance online publication, September 30, 2008; doi:10.1038/sj.bjc.6604484
Clinical Studies
Endometrial stromal sarcoma: a population-based analysis FREE
J K Chan, N M Kawar, J Y Shin, K Osann, L-m Chen, C B Powell and D S Kapp
Br J Cancer 99: 1210-1215; advance online publication, September 23, 2008; doi:10.1038/sj.bjc.6604527
Adjuvant hysterectomy for treatment of residual disease in patients with cervical cancer treated with radiation therapy FREE
T Ota, N Takeshima, T Tabata, K Hasumi and K Takizawa
Br J Cancer 99: 1216-1220; doi:10.1038/sj.bjc.6604619
Breast cancer awareness among older women FREE
L Linsell, C C Burgess and A J Ramirez
Br J Cancer 99: 1221-1225; advance online publication, September 23, 2008; doi:10.1038/sj.bjc.6604668
NEAT: National Epirubicin Adjuvant Trial – toxicity, delivered dose intensity and quality of life FREE
H M Earl, L Hiller, J A Dunn, S Bathers, P Harvey, A Stanley, R J Grieve, R K Agrawal, I N Fernando, A M Brunt, K McAdam, S O'Reilly, D W Rea, D Spooner and C J Poole on behalf of the NEAT Investigators
Br J Cancer 99: 1226-1231; advance online publication, September 16, 2008; doi:10.1038/sj.bjc.6604674
Cost-effectiveness of adjuvant chemotherapy with uracil–tegafur for curatively resected stage III rectal cancer FREE
A Hisashige, S Yoshida and S Kodaira
Br J Cancer 99: 1232-1238; advance online publication, September 16, 2008; doi:10.1038/sj.bjc.6604666
Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients FREE
E Rouits, V Charasson, A Pétain, M Boisdron-Celle, J-P Delord, M Fonck, A Laurand, A-L Poirier, A Morel, E Chatelut, J Robert and E Gamelin
Br J Cancer 99: 1239-1245; advance online publication, September 16, 2008; doi:10.1038/sj.bjc.6604673
Translational Therapeutics
Adiponectin differentially affects gene expression in human mammary epithelial and breast cancer cells FREE
O Treeck, C Lattrich, I Juhasz-Boess, S Buchholz, G Pfeiler and O Ortmann
Br J Cancer 99: 1246-1250; advance online publication, September 30, 2008; doi:10.1038/sj.bjc.6604692
CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype FREE
N A Helsby, W-Y Lo, K Sharples, G Riley, M Murray, K Spells, M Dzhelai, A Simpson and M Findlay
Br J Cancer 99: 1251-1255; doi:10.1038/sj.bjc.6604699
Liposomal encapsulation enhances the antitumour efficacy of the vascular disrupting agent ZD6126 in murine B16.F10 melanoma FREE
M H A M Fens, K J Hill, J Issa, S E Ashton, F R Westwood, D C Blakey, G Storm, A J Ryan and R M Schiffelers
Br J Cancer 99: 1256-1264; advance online publication, September 16, 2008; doi:10.1038/sj.bjc.6604675
Molecular Diagnostics
A novel AKT3 mutation in melanoma tumours and cell lines FREE
M A Davies, K Stemke-Hale, C Tellez, T L Calderone, W Deng, V G Prieto, A J F Lazar, J E Gershenwald and G B Mills
Br J Cancer 99: 1265-1268; advance online publication, September 23, 2008; doi:10.1038/sj.bjc.6604637
C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma FREE
S Mahner, C Baasch, J Schwarz, S Hein, L Wölber, F Jänicke and K Milde-Langosch
Br J Cancer 99: 1269-1275; doi:10.1038/sj.bjc.6604650
PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients FREE
C A Harwood, N R Attard, P O'Donovan, P Chambers, C M Perrett, C M Proby, J M McGregor and P Karran
Br J Cancer 99: 1276-1284; doi:10.1038/sj.bjc.6604665
CD133 expression is an independent prognostic marker for low survival in colorectal cancer FREE
D Horst, L Kriegl, J Engel, T Kirchner and A Jung
Br J Cancer 99: 1285-1289; advance online publication, September 9, 2008; doi:10.1038/sj.bjc.6604664
High expression of TROP2 correlates with poor prognosis in pancreatic cancer FREE
D Fong, P Moser, C Krammel, J M Gostner, R Margreiter, M Mitterer, G Gastl and G Spizzo
Br J Cancer 99: 1290-1295; advance online publication, September 23, 2008; doi:10.1038/sj.bjc.6604677
Is PTEN loss associated with clinical outcome measures in human prostate cancer? FREE
P McCall, C J Witton, S Grimsley, K V Nielsen and J Edwards
Br J Cancer 99: 1296-1301; doi:10.1038/sj.bjc.6604680
Genetics and Genomics
In vitro phosphorylation of BRCA2 by the checkpoint kinase CHEK2 FREE
S Kim, G Mohapatra and D A Haber
Br J Cancer 99: 1302-1306; advance online publication, September 16, 2008; doi:10.1038/sj.bjc.6604644
Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis FREE
A Takeno, I Takemasa, Y Doki, M Yamasaki, H Miyata, S Takiguchi, Y Fujiwara, K Matsubara and M Monden
Br J Cancer 99: 1307-1315; advance online publication, September 30, 2008; doi:10.1038/sj.bjc.6604682
GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group FREE
D M Kweekel, M Koopman, N F Antonini, T Van der Straaten, J W R Nortier, H Gelderblom, C J A Punt and H-J Guchelaar
Br J Cancer 99: 1316-1321; advance online publication, September 16, 2008; doi:10.1038/sj.bjc.6604654
NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer FREE
D Murray, G Horgan, P MacMathuna and P Doran
Br J Cancer 99: 1322-1329; advance online publication, September 30, 2008; doi:10.1038/sj.bjc.6604688
Identification of novel neuroendocrine-specific tumour genes FREE
E Hofsli, T E Wheeler, M Langaas, A Lægreid and L Thommesen
Br J Cancer 99: 1330-1339; advance online publication, September 30, 2008; doi:10.1038/sj.bjc.6604565
Case–control study and meta-analysis of SULT1A1 Arg213His polymorphism for gene, ethnicity and environment interaction for cancer risk FREE
A Kotnis, S Kannan, R Sarin and R Mulherkar
Br J Cancer 99: 1340-1347; doi:10.1038/sj.bjc.6604683
Hypoxia upregulates expression of human endosialin gene via hypoxia-inducible factor 2 FREE
A Ohradanova, K Gradin, M Barathova, M Zatovicova, T Holotnakova, J Kopacek, S Parkkila, L Poellinger, S Pastorekova and J Pastorek
Br J Cancer 99: 1348-1356; advance online publication, September 23, 2008; doi:10.1038/sj.bjc.6604685
TGF-
1 genotype and phenotype in breast cancer and their associations with IGFs and patient survival FREE
L Mu, D Katsaros, L Lu, M Preti, A Durando, R Arisio and H Yu
Br J Cancer 99: 1357-1363; advance online publication, September 30, 2008; doi:10.1038/sj.bjc.6604689
Letters to the Editor
Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience FREE
U Tirelli
Br J Cancer 99: 1364; advance online publication, September 9, 2008; doi:10.1038/sj.bjc.6604648
Reply: Clinical outcome and prognostic factors for patients treated within a phase I study: the Royal Marsden Hospital Experience FREE
D Olmos, H-T Arkenau, J E Ang, J S de Bono, I Judson and S B Kaye
Br J Cancer 99: 1365; doi:10.1038/sj.bjc.6604649
Faecal tumour pyruvate kinase M2: not a good marker for the detection of colorectal adenomas FREE
Y M Shastri and J M Stein
Br J Cancer 99: 1366; advance online publication, September 30, 2008; doi:10.1038/sj.bjc.6604656
Reply: Faecal tumour pyruvate kinase M2: not a good marker for detection of colorectal adenomas FREE
U Haug, S Hundt and H Brenner
Br J Cancer 99: 1367; advance online publication, September 30, 2008; doi:10.1038/sj.bjc.6604679
Resistance to chemotherapy FREE
J Hofmann
Br J Cancer 99: 1368; advance online publication, September 9, 2008; doi:10.1038/sj.bjc.6604663
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
